EVLO Evelo Biosciences Inc

Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.

$1.80
As of 05/25/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/09/2018
Outstanding shares:  53,659,859
Average volume:  265,179
Market cap:   $91,758,359
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFMFL82

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   9.01
PS ratio:   0.00
Return on equity:   737.06%
Net income %:   0.00%